AngioDynamics, Inc. (ANGO)

Market Cap	388.61M
Revenue (ttm)	283.32M
Net Income (ttm)	-41.39M
Shares Out	40.61M
EPS (ttm)	-1.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	232,963
Open	9.89
Previous Close	9.79
Day's Range	9.48 - 9.89
52-Week Range	5.47 - 13.50
Beta	0.52
Analysts	Strong Buy
Price Target	14.00 (+46.29%)
Earnings Date	Apr 2, 2025

About ANGO

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergen...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 27, 2004
• Employees: 748
• Stock Exchange: NASDAQ
• Ticker Symbol: ANGO
• Website: https://www.angiodynamics.com

Financial Performance

In 2024, AngioDynamics's revenue was $303.91 million, a decrease of -10.28% compared to the previous year's $338.75 million. Losses were -$184.35 million, 251.5% more than in 2023.

Analyst Forecast

According to 2 analysts, the average rating for ANGO stock is "Strong Buy." The 12-month stock price forecast is $14.0, which is an increase of 46.29% from the latest price.

Price Target

$14.0

(46.29% upside)

Analyst Consensus: Strong Buy